Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 34 USDMF, 17 CEP/COS, 13 EU WC, 17 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

73 Coating Systems & Additives, 73 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 38 Thickeners and Stabilizers, 38 Solubilizers, 32 Disintegrants & Superdisintegrants, 29 Direct Compression, 27 Granulation, 24 Lubricants & Glidants, 23 Film Formers & Plasticizers, 17 Topical, 16 Taste Masking, 14 Parenteral, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

32 NEWS #PharmaBuzz

32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

9 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

$ Xls

Filters

Metoprolol Succinate

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Qianhao Chemical (Hebei) Co., Ltd

filter Capability Reset all filters

filter Country Reset all filters

01

Qianhao Chemical (Hebei) Co., Ltd

HYDROXYPROPYL METHYL CELLULOSE

Biotech Digital Meet

Not Confirmed

Looking for Pharmaceutical Excipients offered by Qianhao Chemical (Hebei) Co., Ltd? Find Hydroxypropyl Methylcellulose based excipient solutions to address drug delivery challenges on PharmaCompass.

Metoprolol Succinate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers

34 USDMF

17 CEP/COS

13 EU WC

17 NDC API

26 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers

95 FDA Orange Book

30 Europe

27 Australia

33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Evonik

2 Rochem International Inc

6 SPI Pharma

2 Seqens

10 DKSH

6 Faran Shimi Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

5 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Pramukh Pharmachem

4 ACG Worldwide

7 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

30 BASF

1 Clariant

15 Corel Pharma Chem

5 DFE Pharma

2 Finar

12 Gangwal Chemicals

13 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

32 Kerry

5 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

21 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons